Health and Healthcare
Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)
Published:
Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD
The short interest is on the rise overall, but the odd thing is that the short interest in biotech shares is really a mixed bag. Some of the short interest indications doesn’t really look like the short sellers were making the right moves, but time will be the true judge. Here are the key NASDAQ biotech short interest numbers:
Stock (Ticker MAY APRIL CHANGE
Amgen (AMGN) 25.59M 27.99M -8.5%
Gilead (GILD) 12.99M 13.57M -4.2%
Celgene (CELG) 25.9M 24.6M 5%
Genzyme (GENZ) 7.05M 6.75M 4.5%
Medimmune (MEDI) 20.5M 17.2M 18.8%
Biogen-Idec (BIIB) 9.61M 9.09M 5.7%
Amylin Pharma (AMLN) 18.7M 20.0M -6.4%
Imclone (IMCL) 6.26M 7.89M -20.6%
Dendreon (DNDN) 41.6M 33.9M 22.9%
Northfield (NFLD) 6.24M 6.62M -5.7%
Jon C. Ogg
May 25, 2007
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
